Changsheng’s CAR001 Cell Therapy Approved for Groundbreaking Clinical Trials in Cancer Treatment
Rewrite text [Adroddodd gohebydd Times Guo Honghui yn Taipei]Changsheng (6712) has achieved a major breakthrough in the field of cell therapy. Recently the US Food and Drug Administration (FDA) officially approved its new drug CAR001 (CAR-T) to conduct Phase I /IIa clinical trials, becoming the first in the world The allogeneic HLA-G-CAR-BiTE cell therapy approved […]